The MCP-1 -2518(A/G) single nucleotide polymorphism has been shown to be a valuable genetic marker for distant metastasis risk evaluation in NPC patients after radiotherapy [35]. This evidence concerns the gene CCL2 and nasopharyngeal carcinoma.